STOCK TITAN

Teladoc Health Inc Stock Price, News & Analysis

TDOC NYSE

Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.

Teladoc Health (TDOC) delivers whole-person virtual care through AI-driven solutions and integrated digital health services. This news hub provides investors and healthcare professionals with essential updates on the company's strategic initiatives, operational milestones, and market developments.

Access real-time information about earnings announcements, technology partnerships, clinical research breakthroughs, and regulatory updates. Our curated collection features official press releases alongside third-party analysis of TDOC's expanding telehealth capabilities and chronic care management innovations.

Key updates include:

• Quarterly financial results
• Strategic acquisitions
• Clinical study outcomes
• Platform enhancements
• Leadership appointments

Bookmark this page for streamlined tracking of Teladoc Health's progress in transforming healthcare delivery through virtual-first solutions. Combine these updates with our comprehensive company profile for informed decision-making in the evolving digital health sector.

Rhea-AI Summary

Teladoc Health reported mixed Q1 2025 financial results, with revenue declining 3% year-over-year to $629.4 million. The company posted a net loss of $93.0 million ($0.53 per share), including a $59.1 million goodwill impairment charge.

The Integrated Care segment showed positive growth, with revenue up 3% to $389.5 million and improved EBITDA margin of 12.9%. However, BetterHelp segment revenue decreased 11% to $239.9 million with an EBITDA margin of 3.2%.

Key highlights include the acquisition of UpLift Health Technologies for $30 million plus potential earnout of $15 million, expanding mental health coverage to over 100 million lives. The company's outlook for 2025 projects full-year revenue between $2.47-2.58 billion and adjusted EBITDA of $263-304 million, reflecting continued challenges in the BetterHelp segment but stability in Integrated Care operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Teladoc Health has acquired UpLift, a virtual mental health services provider, in a $30 million all-cash deal with potential additional earnout of $15 million. UpLift, which generated approximately $15 million in revenue in 2024, brings access to over 100 million covered lives through health plan relationships and a network of 1,500+ mental health professionals.

The acquisition enables BetterHelp, Teladoc's consumer therapy division, to accept insurance benefits while expanding mental healthcare accessibility. UpLift will maintain its existing leadership under CEO Kyle Talcott and continue managing its provider network, quality oversight, and insurance administration.

This strategic move strengthens Teladoc's position in virtual mental health services, complementing its Integrated Care segment which delivered nearly one million mental health visits in 2024. The transaction closed on April 30, 2025, with UpLift's results to be included in BetterHelp's reporting segment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC), the global leader in virtual care, has scheduled its first quarter 2025 financial results announcement for Wednesday, April 30, 2025, after market close. The company will host a conference call at 4:30 p.m. ET the same day to review the results.

Participants can join via phone by dialing 1-833-470-1428 (U.S.) with access code #309585. International dial-in numbers are available through a dedicated link. A live audio webcast will be accessible at the company's investor relations website, with a replay available for approximately 90 days after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has launched its next generation Cardiometabolic Health Program aimed at improving population health and preventing the progression of diabetes, hypertension, and obesity. The program focuses on nine key health factors: diet, physical activity, sleep, stress management, weight, blood lipids, blood glucose, blood pressure, and nicotine exposure.

New features include:

  • BetterSleep premium app subscription
  • Access to registered dietitians
  • Proactive health coaching
  • At-home testing for cardiometabolic measures
  • Dynamic health insights from connected devices
  • Integration with Teladoc's 24/7 care services

The program has demonstrated strong results, with 58% of participants in the diabetes management program achieving remission-level A1c, and 88% of hypertension program participants improving or maintaining blood pressure after one year. Teladoc Health is backing the program's effectiveness by putting 100% of program fees at risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has formed a strategic partnership with Carrum Health to integrate Centers of Excellence (COE) specialty care services into their platform. The collaboration enables seamless referrals from Teladoc providers to Carrum's nationwide network of vetted healthcare providers through Teladoc's Connected Care program.

The partnership addresses employer concerns about managing multiple point solutions, with 70% of employers worried about lack of coordination between healthcare services. With over 93 million members, Teladoc Health will offer single sign-on access through their unified app, allowing eligible members to access Carrum's surgical care, cancer care, and substance use treatment services.

The integration aims to streamline administration, improve member engagement, and deliver cost savings for employers amid rising healthcare costs, with PwC predicting an 8% increase in healthcare costs in 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.39%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has announced an expansion of its connected care partnerships across new care categories. The company is integrating new digital health partners into its Prism care platform, including services for digestive health, centers of excellence, fertility, and family building.

Key new partnerships include:

  • Carrot Fertility for fertility, family building, and hormonal health support
  • Carrum Health for specialty care centers of excellence
  • Cylinder Health for digestive health, showing 13% engagement
  • Oshi Health for virtual GI care with ROI guarantee

The expansion addresses growing demand for integrated virtual care solutions, with over 70% of large employers concerned about siloed care experiences. Teladoc Health, serving more than 93 million members, offers streamlined contracting and administration through its unified app with single sign-on capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
partnership
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has announced a pharmacy integration partnership with Gifthealth, Eli Lilly's LillyDirect pharmacy partner, to provide self-pay access to FDA-approved Zepbound® (tirzepatide) for members enrolled in its Comprehensive Weight Care Program who lack GLP-1 insurance coverage.

The integration will enable eligible Teladoc Health members to receive prescribed Zepbound® directly at home, with the company's care teams maintaining full visibility of the fulfillment process. The program includes:

  • Multi-disciplinary support from licensed clinicians trained in obesity medicine
  • Access to registered dietitians and health coaches
  • A connected digital scale
  • Personalized lifestyle coaching
  • Nutrition counseling
  • Mental health support
  • Behavior change resources
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
-
Rhea-AI Summary

Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to 21 new employees following its acquisition of Catapult Health on February 28, 2025. The awards include:

- 19 Catapult Health employees received 365,282 restricted stock units and 324,270 performance stock units

- 2 additional non-executive employees received 155,523 restricted stock units and 125,523 performance stock units (with potential earnings up to 251,046 shares)

The restricted stock units vest over 2-3 years based on continued service. Performance stock units are tied to various financial and operational metrics of both companies. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
management
-
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has announced significant enhancements to its proprietary Prism care delivery platform, strengthening care coordination between digital and in-person providers. The platform updates include advanced referral capabilities, AI-enabled clinical transcription, and improved data integration tools.

Key improvements feature automatic screening recommendations, seamless referrals to Connected Care Partners (showing a 40% year-over-year increase in internal referrals), and expanded closed-loop referrals to in-network community providers. The platform serves over 93 million Americans through health plans and employers, with 90% of virtual urgent care visits occurring within 30 minutes of member outreach.

The enhanced platform leverages data insights and responsible AI to improve care provider experience and visit value, supporting clinicians in addressing care gaps and improving population health outcomes for employers and health plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
none
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) reported its Full Year and Fourth Quarter 2024 results, showing overall revenue decline. Full Year 2024 revenue decreased 1% to $2,569.6 million, while Q4 2024 revenue fell 3% to $640.5 million.

The company recorded a significant Full Year 2024 net loss of $1,001.2 million ($5.87 per share), including a non-cash goodwill impairment charge of $790.0 million related to BetterHelp segment. Q4 2024 net loss was $48.4 million ($0.28 per share).

Key performance metrics showed mixed results:

  • Integrated Care segment revenue grew 2% to $390.7 million in Q4
  • BetterHelp segment revenue declined 10% to $249.8 million
  • Full Year adjusted EBITDA decreased 5% to $310.7 million
  • Cash position stood at $1,298.3 million as of December 31, 2024

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.56%
Tags

FAQ

What is the current stock price of Teladoc Health (TDOC)?

The current stock price of Teladoc Health (TDOC) is $6.99 as of May 1, 2025.

What is the market cap of Teladoc Health (TDOC)?

The market cap of Teladoc Health (TDOC) is approximately 1.2B.
Teladoc Health Inc

NYSE:TDOC

TDOC Rankings

TDOC Stock Data

1.24B
173.56M
0.81%
75.9%
14.41%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
PURCHASE